Viewing Study NCT00301093


Ignite Creation Date: 2025-12-25 @ 1:20 AM
Ignite Modification Date: 2026-01-25 @ 4:40 PM
Study NCT ID: NCT00301093
Status: COMPLETED
Last Update Posted: 2020-10-28
First Post: 2006-03-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Vaccine Therapy and Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia
Sponsor: Dana-Farber Cancer Institute
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Leukemia View
Keywords:

Keywords

Keyword Brief Keyword Text View
None chronic phase chronic myelogenous leukemia View
None Philadelphia chromosome positive chronic myelogenous leukemia View